{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Belleville",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81784",
      "recalling_firm": "US Pharmaceuticals Inc.",
      "address_1": "681 Main St Ste 27",
      "address_2": "",
      "postal_code": "07109-3471",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0427-2019",
      "product_description": "Medline Remedy Essential Barrier Skin Protectant Ointment (petrolatum 59%) packaged in a) 2 oz tubes (NDC 53329-302-14) and b) 6 oz tubes (NDC 53329-302-41), Medline Industries Inc., Manufactured for Medline Industries Inc., Mundelien, IL 60060.",
      "product_quantity": "7020 units",
      "reason_for_recall": "GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample",
      "recall_initiation_date": "20181207",
      "center_classification_date": "20190204",
      "termination_date": "20231106",
      "report_date": "20190213",
      "code_info": "Lot # a) and b): 44G17, Exp. 05/2019",
      "more_code_info": ""
    }
  ]
}